Already available in several countries since 2019, the headset is designed to address depression by directly targeting brain function. Used to treat several allergic and inflammatory conditions, the higher-dose presentation is intended to reduce injection burden and increase convenience. 1 pain relief option in Mexico—to the US market, offering a familiar and trusted product to Hispanic consumers seeking culturally resonant health solutions. Bayer noted that as the Hispanic population grows, the brand aims to meet the community’s needs by expanding access to a product already widely recognized throughout Latin America. The tablets will be offered in 30-count bottles of 400 mg and 90-count bottles of 100 mg.